We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage.

Glycogen synthase kinase-3beta (GSK3beta) is a central figure in Wnt signaling, in which its activity is controlled by regulatory binding proteins. Here we show that binding proteins outside the Wnt pathway also control the activity of GSK3beta. DNA damage induced by camptothecin, which activates the tumor suppressor p53, was found to activate GSK3beta. This activation occurred by a phosphorylation-independent mechanism involving direct binding of GSK3beta to p53, which was confined to the nucleus where p53 is localized, and mutated p53 (R175H) bound but did not activate GSK3beta. Activation of GSK3 promoted responses to p53 including increases in p21 levels and caspase-3 activity. Thus, after DNA damage there is a direct interaction between p53 and GSK3beta, and these proteins act in concert to regulate cellular responses to DNA damage.

Pubmed ID: 12048243 RIS Download

Mesh terms: Base Sequence | Calcium-Calmodulin-Dependent Protein Kinases | Camptothecin | Cell Nucleus | Cytosol | DNA Damage | DNA Primers | Glycogen Synthase Kinase 3 | Glycogen Synthase Kinases | Humans | Kinetics | Neuroblastoma | Polymerase Chain Reaction | Protein Binding | Recombinant Proteins | Tumor Cells, Cultured | Tumor Suppressor Protein p53

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.